Smith & Nephew (LON:SN) Stock Passes Above 200 Day Moving Average - What's Next?

Key Points

• Smith & Nephew's stock price has surpassed its two hundred day moving average of GBX 1,175.86, reaching a recent high of GBX 1,328.50 during trading.
• Analysts have raised target prices for Smith & Nephew, with JPMorgan upgrading it to GBX 1,438 and Deutsche Bank to GBX 1,400, while maintaining a consensus rating of "Hold".
• Insiders have been active, with significant share purchases totaling £12,947,701 in the last 90 days, indicating confidence in the company's future performance.

Smith & Nephew plc (LON:SN - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,175.86 ($15.66) and traded as high as GBX 1,328.50 ($17.70). Smith & Nephew shares last traded at GBX 1,324 ($17.64), with a volume of 2,986,359 shares traded.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. JPMorgan Chase & Co. raised their target price on Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the stock an "overweight" rating in a research report on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft raised their target price on Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the stock a "hold" rating in a research report on Wednesday, August 6th. Finally, Berenberg Bank raised their target price on Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the stock a "hold" rating in a research report on Thursday, August 7th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of GBX 1,379.33.

Smith & Nephew Stock Performance

The company has a 50-day moving average price of GBX 1,364.40 and a two-hundred day moving average price of GBX 1,175.86. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The stock has a market capitalization of £14.37 billion, a P/E ratio of 47.20, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62.

Insider Transactions at Smith & Nephew

In other Smith & Nephew news, insider Jo Hallas acquired 389 shares of the stock in a transaction dated Friday, August 22nd. The stock was purchased at an average cost of GBX 1,384 per share, with a total value of £5,383.76. Also, insider Katarzyna Mazur Hofsaess acquired 541 shares of the stock in a transaction dated Friday, August 22nd. The stock was acquired at an average cost of GBX 1,385 per share, with a total value of £7,492.85. In the last 90 days, insiders purchased 4,811 shares of company stock worth $12,947,701. Corporate insiders own 0.19% of the company's stock.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.